M. Ayusawa, T. Sonobe, S. Uemura, Shunnichi Ogawa, Yoshikazu Nakamura, N. Kiyosawa, M. Ishii, K. Harada
2005.4.1PEDIATRICS INTERNATIONAL
tlooto Summary
New guidelines for Kawasaki Disease are explained, major alterations are interpretation of cases with 4 or fewer febrile days shortened by early intravenous immunoglobulin treatment, and the clinical importance of atypical cases.
Abstract
Abstract Diagnostic guidelines for Kawasaki Disease was revised to meet the present situation in 2002. This issue intends to explain new guidelines and their backgrounds. Major alterations are interpretation of cases with 4 or fewer febrile days shortened by early intravenous immunoglobulin treatment, and the clinical importance of atypical (incomplete, or suspected) cases.
Citation format
AYUSAWA, M., et al. Revision of diagnostic guidelines for kawasaki disease (the 5th revised edition). PEDIATRICS INTERNATIONAL, 2005, 47.